Connective Tissue Graft Versus Mucograft Collagen Matrix for Coverage of Multiple Gingival Recession Defects
Primary Purpose
Gingival Recession
Status
Completed
Phase
Phase 4
Locations
International
Study Type
Interventional
Intervention
Autologous connective tissue graft with rotated papilla flap
Collagen matrix construct (Mucograft)
Sponsored by
About this trial
This is an interventional treatment trial for Gingival Recession focused on measuring gingival recession, root coverage, periodontal surgery, collagen matrix, mucograft, multiple exposed teeth
Eligibility Criteria
Inclusion Criteria:
- 2-4 adjacent gingival recession (one at least 3 mm deep)
Exclusion Criteria:
- Interdental attachment loss greater than 1 mm at recession sites
Sites / Locations
- ICPDOI
- Praxis Dr. Halben
- Praxis Prof Huerzeler - Dr Zuhr
- Praxis Prof Wachtel - Dr Bolz
- Praxis Prof. Topoll
- Clinic Fourmousis
- University of FLorence
- Practice Prof Giulio Rasperini
- University of Pisa
- Clinia Zabalegui
- Clinica Guerrero
- Praxis Wallkamm
- Praxis Burkhardt
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Experimental
Arm Label
Autologous connective tissue graft
Collagen Matrix Construct
Arm Description
Soft tissue harvested from patient palate
Mucograft collagen matrix manufactured by Geistlich AG, Switzerland
Outcomes
Primary Outcome Measures
Time to recovery after surgery
Time to recover after surgery assessed by diary and post'op follow up professional assessment
Secondary Outcome Measures
Complete root coverage
Frequency of complete root coverage
Percentage of root coverage
Percentage of the exposed tooth root covered after surgical intervention
Esthetics
Professional assessment by blind assessor of the esthetic result
Full Information
NCT ID
NCT01440426
First Posted
September 22, 2011
Last Updated
July 12, 2018
Sponsor
Maurizio Tonetti
Collaborators
The European Research Group on Periodontology (ERGOPerio)
1. Study Identification
Unique Protocol Identification Number
NCT01440426
Brief Title
Connective Tissue Graft Versus Mucograft Collagen Matrix for Coverage of Multiple Gingival Recession Defects
Official Title
Connective Tissue Graft vs Mucograft Collagen Matrix for Coverage of Multiple Gingival Recession Defects Randomized Controlled Clinical Trial Assessing Superiority in Health Related Quality of Life and Non-Inferiority in Root Coverage
Study Type
Interventional
2. Study Status
Record Verification Date
July 2018
Overall Recruitment Status
Completed
Study Start Date
September 2011 (undefined)
Primary Completion Date
June 2015 (Actual)
Study Completion Date
June 2015 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Maurizio Tonetti
Collaborators
The European Research Group on Periodontology (ERGOPerio)
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
This study deals with coverage of multiple denuded roots. The current standard treatment requires surgical correction and uses soft tissue taken from the roof of the mouth to enhance results. The hypothesis of this trial is that a synthetic collagen matrix (called Mucograft) can be used to replace soft tissue taken from the subject. If the collagen matrix will prove to be equally as effective as the patient own tissue, it will be possible to avoid a more extensive surgery and decrease pain and discomfort.
Detailed Description
Objectives The main objective of this study is to assess if the Mucograft Collagen Matrix reduces morbidity, shortens time to recovery and improves patient based outcomes with respect to the use of autologous connective tissue graft harvested from the patient own palate when used to obtain root coverage of multiple adjacent gingival recessions.
The secondary objective is to assess the non-inferiority - in terms of complete root coverage, percentage of root coverage and professional evaluation of aesthetics - of the use of Mucograft Collagen Matrix and autologous connective tissue harvested from the patient's own palate.
Design and Outcomes This will be a parallel group, standard of care-controlled, assessor-blind, randomized, multicenter, multinational, clinical trial.
The statistical design will be a superiority trial in terms of the primary outcomes (patient based outcomes) and non-inferiority trial in terms of the professional outcomes measuring root coverage and aesthetics.
Sample size has been estimated in 140 subjects per treatment arm using a pilot case series analyzed with a multilevel statistical approach and a non inferiority margin of 0.25 mm in recession coverage.
Randomization will be performed by computer generated random codes, using random permuted blocks with a block size of 4 to avoid uneven splits and minimization for the key prognostic factor cigarette smoking. Allocation will be concealed to the surgeons until completion of preparation of the recipient bed by opaque envelopes. A central study registrar will perform patient registration.
Study locations will include academic centers and a practice-based research network in Italy, Switzerland, Germany, Belgium, France, Spain and Greece.
A single examiner, blind with respect to the treatment assignment, will perform all measurements at each center. Trained personnel not involved with the surgical intervention will: i) administer patient questionnaires, ii) provide instructions and collect patient diaries. A single calibrated investigator with specific experience in using the specific score will centrally perform assessment of esthetic scores on standardized digital images.
A biostatistician blind with respect to treatment assignment will perform the analysis.
Interventions and Duration The two intervention groups will consist of surgery with connective tissue graft (standard of care control) and surgery with the application of Mucograft Collagen Matrix (MCM, Test group). Experienced clinicians will deliver treatment consisting of root coverage surgery using coronally advanced flaps, the most utilized procedure for coverage of multiple recessions. Surgery will be standardized and the same procedures/materials will be employed to ensure consistency.
Follow-up of individual patients will be 6 months (to be extended to 3 years if funding will be available)
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Gingival Recession
Keywords
gingival recession, root coverage, periodontal surgery, collagen matrix, mucograft, multiple exposed teeth
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
187 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Autologous connective tissue graft
Arm Type
Active Comparator
Arm Description
Soft tissue harvested from patient palate
Arm Title
Collagen Matrix Construct
Arm Type
Experimental
Arm Description
Mucograft collagen matrix manufactured by Geistlich AG, Switzerland
Intervention Type
Procedure
Intervention Name(s)
Autologous connective tissue graft with rotated papilla flap
Other Intervention Name(s)
Subepithelial connective tissue graft
Intervention Description
Subepithelial connective tissue graft harvested from hard palate
Intervention Type
Device
Intervention Name(s)
Collagen matrix construct (Mucograft)
Other Intervention Name(s)
Mucograft gingival augmentation
Intervention Description
Mucograft Collagen Matrix combined with rotated papilla flap
Primary Outcome Measure Information:
Title
Time to recovery after surgery
Description
Time to recover after surgery assessed by diary and post'op follow up professional assessment
Time Frame
3 months
Secondary Outcome Measure Information:
Title
Complete root coverage
Description
Frequency of complete root coverage
Time Frame
6 months
Title
Percentage of root coverage
Description
Percentage of the exposed tooth root covered after surgical intervention
Time Frame
6 months
Title
Esthetics
Description
Professional assessment by blind assessor of the esthetic result
Time Frame
6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
2-4 adjacent gingival recession (one at least 3 mm deep)
Exclusion Criteria:
Interdental attachment loss greater than 1 mm at recession sites
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Maurizio Tonetti, DMD PhD
Organizational Affiliation
The European Research Group on Periodontology (ERGOPerio)
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Pierpaolo COrtellini, MD
Organizational Affiliation
The European Research Group on Periodontology (ERGOPerio)
Official's Role
Principal Investigator
Facility Information:
Facility Name
ICPDOI
City
Brussels
Country
Belgium
Facility Name
Praxis Dr. Halben
City
Hamburg
Country
Germany
Facility Name
Praxis Prof Huerzeler - Dr Zuhr
City
Munich
Country
Germany
Facility Name
Praxis Prof Wachtel - Dr Bolz
City
Munich
Country
Germany
Facility Name
Praxis Prof. Topoll
City
Munster
Country
Germany
Facility Name
Clinic Fourmousis
City
Athens
Country
Greece
Facility Name
University of FLorence
City
Florence
Country
Italy
Facility Name
Practice Prof Giulio Rasperini
City
Piacenza
Country
Italy
Facility Name
University of Pisa
City
Pisa
Country
Italy
Facility Name
Clinia Zabalegui
City
Bilbao
Country
Spain
Facility Name
Clinica Guerrero
City
Malaga
Country
Spain
Facility Name
Praxis Wallkamm
City
Langenthal
Country
Switzerland
Facility Name
Praxis Burkhardt
City
Zurich
Country
Switzerland
12. IPD Sharing Statement
Learn more about this trial
Connective Tissue Graft Versus Mucograft Collagen Matrix for Coverage of Multiple Gingival Recession Defects
We'll reach out to this number within 24 hrs